California man admits to scamming DoorDash out of $2.5 million using fake deliveries
California man admits to scamming DoorDash out of $2.5 million using fake deliveries
Show Caption
Hide Caption
Expert take: Does buy now, pay later help or hurt your finances?
Priya Malani, CEO of Stash Wealth, and Paula Pant, host of the Afford Anything podcast talk buy now, pay later.
A former delivery driver has pleaded guilty to conspiring with several others to steal over $2.5 million from DoorDash, a San Francisco-based food delivery company, federal prosecutors said.
Sayee Chaitanya Reddy Devagiri, 30, of Newport Beach, California, pleaded guilty on May 13 to one count of conspiracy to commit wire fraud, according to the U.S. Attorney's Office for the Northern District of California. Prosecutors said Devagiri admitted to working with three others and a former employee of DoorDash in a fraud scheme that targeted the company between 2020 and 2021.
In the scheme, the group caused DoorDash to pay for deliveries that never occurred, according to prosecutors. Prosecutors said the scheme resulted in more than $2.5 million in fraudulent payments.
Devagiri was arrested and indicted alongside Manaswi Mandadapu, 29; Matheus Duarte, 29; and Hari Vamsi Anne, 30, in October 2024, according to prosecutors. All four were charged with a single count of conspiracy to commit wire fraud.
Mandadapu pleaded guilty to the charge on May 6, prosecutors said. Duarte and Anne previously pleaded not guilty and are scheduled to appear in court on July 22, The Los Angeles Times reported.
The former DoorDash employee involved in the scheme, Tyler Thomas Bottenhorn, was charged in a separate indictment in September 2022 and pleaded guilty to conspiracy to commit wire fraud in November 2023, according to prosecutors.
Devagiri is expected to appear in court for a status hearing on September 16, prosecutors said. He faces a maximum statutory penalty of 20 years in prison and a fine of $250,000.
'Fundamentally unfair': DoorDash to pay millions to dashers after company pocketed tips
Fraudulent accounts, manipulated DoorDash software
DoorDash provides food delivery services to customers who place orders on the platform. Drivers who work for the company fulfill those orders by picking up ordered items from restaurants and other merchants and delivering them to customers.
According to an indictment unsealed in October 2024, the group worked together between November 2020 to February 2021. During that period, Devagiri, along with Mandadapu, Duarte, and Anne, created multiple fraudulent customer and driver accounts with DoorDash, the indictment states.
The group used the fraudulent customer accounts to place "high value" orders from restaurants across Northern California, including Santa Clara County, according to the indictment. They then utilized an employee's credentials to access DoorDash's computer systems and software.
The indictment further alleged that the group used the computer systems to manually reassign DoorDash orders placed by their fraudulent customer accounts to their driver accounts. Prosecutors said Devagiri then would report the orders had been delivered on the driver accounts when they had not and manipulated the software to prompt DoorDash to pay the driver accounts for the deliveries that never occurred.
'Senseless act of violence': DoorDash driver shot after arriving at wrong house; NY highway official arrested
Devagiri also used the DoorDash software to change the orders from 'complete' statuses to 'in process' statuses and reassigned the orders to driver accounts that the group controlled, according to the indictment. Prosecutors said Devagiri repeated this process, which took less than five minutes, hundreds of times for many orders.
In total, the group stole over $2.5 million and received payments through bank accounts controlled by Devagiri Mandadapu, Duarte, and Anne, the indictment states.
According to the indictment, the group gained access to the software by using credentials that belonged to Bottenhorn, who was a resident of Solano County, California. He briefly worked for DoorDash in 2020. After pleading guilty in 2023, prosecutors said Bottenhorn admitted to being involved in the scheme to defraud the company.
Devagiri Mandadapu, Duarte, and Anne were all arrested on Oct. 4, 2024, prosecutors said. Devagiri and Mandadapu were taken into custody in Newport Beach and later released on bond. Duarte was arrested in Mountain House, California, and was also released on bond.
Anne was arrested in Cypress, Texas, and was detained in Houston pending further proceedings, according to prosecutors.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Wanted man arrested for reckless driving, other charges in Mt. Juliet after making DoorDash delivery
MT. JULIET, Tenn. (WKRN) — A DoorDash driver is facing multiple charges after a traffic stop for speeding in Mt. Juliet Saturday night reportedly led to the discovery of drugs, as well as an outstanding warrant. According to the Mt. Juliet Police Department, an officer spotted a Jeep Renegade 'flying down' Interstate 40 West, going 93 mph in a 70 mph zone, on Saturday, June 7. However, after the vehicle was safely stopped, law enforcement realized this wasn't a simple speeding case. Several injured after skydiving plane crashes in Tullahoma 'The driver—a 34-year-old man from Nashville—had just dropped off a DoorDash delivery and was still in a rush, driving recklessly and endangering others on the road,' officials said. The MJPD said the officer discovered the driver had an outstanding warrant out of Nashville for violation of probation, which was tied to a felony aggravated assault conviction. In addition, the man was reportedly driving on a revoked license. Then, when authorities searched the vehicle, they said they found five chalky blue pills — suspected to be pressed fentanyl — hidden in a cigarette pack. Law enforcement said they arrested the driver, who now faces charges for reckless driving, driving on a revoked license, possession of fentanyl, and the outstanding warrant. Child helps Sumner County authorities find burglary suspect 'We are grateful for the vigilance and hard work of our officers, who are always watching out for the safety of MJ,' the police department posted on social media. No additional details were arrested about this incident, including the identity of the man who was taken into custody. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
2 hours ago
- Yahoo
SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy
VANCOUVER, British Columbia & TOKYO & WALTHAM, Mass., June 08, 2025--(BUSINESS WIRE)--SOLVE FSHD, a venture philanthropy organization dedicated to accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD), and Modalis Therapeutics Corporation (TSE 4883; "Modalis"), a CRISPR-based epigenome editing therapeutics company focused on rare genetic diseases, today announced a strategic collaboration to develop an innovative therapy for FSHD, a debilitating muscular disorder affecting approximately 1 million individuals worldwide. The novel therapy leverages Modalis's proprietary CRISPR-GNDM® (Guide Nucleotide-Directed Modulation) technology, which can dynamically modulate gene expression without introducing double-strand DNA breaks. SOLVE FSHD will provide strategic funding to support the development of Modalis's MDL-103 program. MDL-103 is an innovative therapeutic solution that continuously suppresses the expression of the DUX4 gene, the toxic disease-causing gene for FSHD, which becomes abnormally activated due to epigenetic changes in the D4Z4 repeat region on chromosome 4. MDL-103 is designed to have durable activity over long periods of time under the control of a strong, muscle-specific promoter, and is delivered to the muscles of patients using a muscle-tropic AAV delivery system. Modalis's CRISPR-GNDM® technology has the potential to transform the treatment of FSHD by epigenetically silencing the expression of DUX4. "SOLVE FSHD is pleased to partner with Modalis and to add them to our diverse portfolio of collaborators that are advancing potential therapies for FSHD," stated Eva Chin, Executive Director of SOLVE FSHD. "SOLVE FSHD identified Modalis as a company committed to finding a cure for this debilitating condition. We were impressed by their unique approach to targeting the epigenetic cause of FSHD, using a platform technology that has shown promise in other neuromuscular diseases. We believe that the support from SOLVE FSHD will allow Modalis to accelerate the advancement of MDL-103 into clinical trials." "We are delighted to be working in partnership with SOLVE FSHD and greatly appreciate the invaluable support for the development of MDL-103," said Haru Morita, CEO of Modalis. "This strategic collaboration is a strong validation of Modalis's CRISPR-GNDM® technology and our MDL-103 program. As a pioneer in this technology, we have demonstrated promising long-term drug efficacy in mouse models, shown durable target engagement and safety in non-human primates, and exhibited excellent biodistribution in neuromuscular disorders. We believe that MDL-103, which incorporates CRISPR-GNDM® technology with a muscle tropic AAV delivery system, has significant potential as a breakthrough treatment for FSHD." About SOLVE FSHD SOLVE FSHD is a venture philanthropic organization established to catalyze innovation and accelerate key research in finding a cure for FSHD. Established by renowned Canadian entrepreneur and philanthropist, Chip Wilson, the Wilson family has committed $100 million to kick-start funding into projects that support the organizations' mission to solve FSHD by 2027. The goal of SOLVE FSHD is to find a solution that can slow down or stop muscle degeneration, increase muscle regeneration and strength, and improve the quality of life for those living with FSHD, visit About Modalis Therapeutics Corporation Modalis was founded in 2016 and conducts research and development activities in Massachusetts, USA. Modalis is a pioneering leader in the field of epigenetic medicine. Modalis develops therapeutics for patients suffering from serious genetic disorders such as neuromuscular diseases, CNS diseases, and cardiomyopathies. Modalis's proprietary CRISPR-GNDM® technology is capable of specifically up or down modulating the expression of disease-relevant genes without introducing double-strand DNA breaks. For more information, visit View source version on Contacts SOLVE FSHDAlexandra Grant, House of Wilsonalexandrag@ Modalis Therapeutics CorporationCorporate Planning Departmentmedia@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
Five members of north Minneapolis gang convicted on RICO, drugs charges
Five members of north Minneapolis gang convicted on RICO, drugs charges originally appeared on Bring Me The News. Five members of a north Minneapolis gang were convicted in federal court last week on charges including murder. On Thursday, a federal jury convicted five members of the Highs gang on various charges. The gang operates north of West Broadway Avenue in North Minneapolis. As members of the gang, the defendants were expected to retaliate against the rival Lows gang, which operates south of West Broadway Avenue, according to the U.S. Attorney's Office. The members convicted are: Tyreese Giles, 24 Trevaun Robinson, 29 William Banks, 35 Gregory Brown, 35 Josiah Taylor, 31 Giles, Robinson, Banks and Brown were convicted on federal RICO conspiracy charges. Giles was also convicted of committing a murder on behalf of the gang on Sept. 9, 2021, when he traveled to a store in Lows territory and fatally shot a Lows member, an apparent retaliatory attack to the killing of a Highs member just a few hours earlier at a Minneapolis barbershop. Taylor was convicted of conspiring to distribute controlled substances and possessing a firearm in furtherance of drug trafficking. 'The Highs have long terrorized north Minneapolis, bringing drugs, violence, and murder into our community,' Acting U.S. Attorney Joseph H. Thompson said in a statement. 'This verdict represents yet another step in our fight against gang violence. I want to thank the coalition of federal, state, and local law enforcement partners who joined together to investigate and prosecute this violent criminal street gang. I also want to thank the Justice Department's Violent Crime & Racketeering Section for lending their expertise and partnering with the U.S. Attorney's Office on our RICO cases.' The trial was the second of back-to-back trials involving members of the Highs gang. The third trial will begin Monday. In total, more than 40 defendants are charged in the case. This story was originally reported by Bring Me The News on Jun 8, 2025, where it first appeared.